Health Dictionary Find a Doctor

Renal tubular acidosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] ; Aditya Ganti M.B.B.S. [3] Syed Ahsan Hussain, M.D.[4] Jogeet Singh Sekhon, M.D. [5]

For patient information, click here
Synonyms and keywords: RTA

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Kidneys serve as a buffering system to maintain acid-base balance. Kidneys reabsorb the filtered bicarbonate and excrete acid to maintain acid-base balance. HCO3 reabsorption is facilitated by Na-H and proton pumps. Collecting tubules serve the function of excretion of acid. When ever there is disruption in the normal physiological mechanisms of tubular system of kidneys acidosis sets in. . Potassium is the most common electrolyte abnormality that can be noticed with renal tubular acidosis. It can be either hypokalemic renal tubular acidosis or hyperkalemic renal tubular acidosis. Renal tubular acidosis can be classified into type 1 (distal), type 2 (proximal), type 4 (hypoaldosteronism) and voltage-dependent RTA. Genetic mutations are the most common etiology for renal tubular acidosis. If left untreated renal tubular acidosis leads to growth failure and chronic kidney failure. Urine pH is the gold standard test for the diagnosis of renal tubular acidosis. Alkalization of the urine along with correction of electrolyte abnormalities is the mainstay of treatment in patients diagnosed by renal tubular acidosis. Sodium bicarbonate with potassium replacement are the medications recommended along with correction of underlying cause.

Historical Perspective

Renal tubular acidosis was first described as separate entity by Dr. Lightwood in 1935. Later Dr.Butler in 1936 described the pathophysiology and genetic inheritance of renal tubular acidosis in the children.

Classification

Based on underlying defect in concentration of urine process in renal tubule, renal tubular acidosis can be classified into type 1 (distal), type 2 (proximal), type 4 (hypoaldosteronism) and voltage-dependent RTA.

Pathophysiology

Kidneys reabsorb the filtered bicarbonate and excrete acid to maintain acid-base balance. HCO3 reabsorption is facilitated by Na-H and proton pumps. Collecting tubules serve the function of excretion of acid. Renal tubular acidosis is described as any one of a number of disorders, in which either of above buffering mechanism is impaired. Potassium is the most common electrolyte abnormality that can be noticed with renal tubular acidosis. It can be either hypokalemic renal tubular acidosis or hyperkalemic renal tubular acidosis. Mode of inheritance can autosomal dominant or recessive depending upon type of disease abnormality, Common genes involved include ATP6V1B1, ATP6V0A4, SLC4A1.

Causes

Primary causes of renal tubular acidosis include genetic mutations causing defects in the kidney anion exchanger [kAE1] in distal tubule intercalated cells and congenital adrenal hyperplasia. Secondary causes include medications and autoimmune diseases.

Differentiating Renal tubular acidosis from Other Diseases

Renal tubular acidosis must be differentiated form other diseases as most of them have a similar presentation of acidosis on ABG, dehydration (nausea and vomiting) and specific history pertaining to underlying etiology.

Epidemiology and Demographics

The estimated annual incidence of distal renal tubular acidosis is 10 in 100,000 population. Renal tubular acidosis is more common in infants than other group of population. There is racial predilection for renal tubular acidosis.

Risk Factors

Common risk factors in the development of renal tubular acidosis include childhoodurinary tract obstructiondiabetes mellitusprimary biliary cirrhosisnephrocalcinosisnephrolithiasisAmphotericin-B therapycisplatinumUntreated adrenal insufficiency.

Screening

Screening for renal tubular acidosis is usually not recommended for asymptomatic patients. Screening is only recommended for patients with increased risk of having proximal RTA or metabolic disorders associated with the development of Fanconi syndrome.

Natural History, Complications, and Prognosis

If left untreated renal tubular acidosis leads to growth failure and chronic kidney failure. Common complications associated with renal tubular acidosis include volume depletion, electrolyte disturbances, nephrocalcinosis, osteoporosis, growth retardation, renal rickets. Prognosis of renal tubular acidosis is generally good with appropriate therapy.

Diagnosis

Diagnostic Study of Choice

Urine pH is the gold standard test for the diagnosis of renal tubular acidosis.

History and Symptoms

Patients with renal tubular acidosis can present with acute or chronic onset of symptoms. Patients usually doesn’t have a typical history or symptoms. Common symptoms of renal tubular acidosis include vomiting, dehydration and electrolyte abnormalities with acidosis.

Physical Examination

Patients with acute onset of renal tubular acidosis appear confused and stupor where as with chronic acidosis usually appear tired.

Laboratory Findings

The diagnosis of renal tubular acidosis should be considered in any patient presenting with metabolic acidosis.The first step in diagnosing metabolic acidosis includes measuring the blood pH. The next steps includes measurement of urine pH and estimation of urinary ammonium excretion.

Electrocardiogram

Electrocardiogram findings associated with renal tubular acidosis include changes due to potassium levels. Peaked T waves are the earliest sign of hyperkalemia. where as hypokalemia presents with ST segment depression, decreased T wave amplitude, and prominent U waves.

X-ray

Electrocardiogram findings associated with renal tubular acidosis include changes due to potassium levels. Peaked T waves are the earliest sign of hyperkalemia. where as hypokalemia presents with ST segment depression, decreased T wave amplitude, and prominent U waves.

Echocardiography and Ultrasound

There are no echocardiography/ultrasound findings associated with renal tubular acidosis.

CT scan

There are no CT scan findings associated with renal tubular acidosis.

MRI

There are no MRI findings associated with renal tubular acidosis.

Other Imaging Findings

There are no specific imaging findings associated with renal tubular acidosis. However, imaging modalities can be helpful in diagnosing underlying complications of renal disease.

Other Diagnostic Studies

There are no other diagnostic studies associated with renal tubular acidosis.

Treatment

Medical Therapy

Alkalization of the urine along with correction of electrolyte abnormalities is the mainstay of treatment in patients diagnosed by renal tubular acidosis. Sodium bicarbonate with potassium replacement are the medications recommended along with correction of underlying cause.

Surgery

Surgical intervention is not recommended for the management of renal tubular acidosis.

Primary Prevention

There are no effective primary preventive measures for renal tubular acidosis. However, preventive approaches can be helpful in the case of Fanconi syndrome secondary to toxin exposure which includes regulation of the use of medications responsible in high-risk groups with caution.

Secondary Prevention

Secondary preventive measures of renal tubular acidosis are similar to primary prevention.

References


Template:WikiDoc Sources

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Renal tubular acidosis was first described as separate entity by Dr. Lightwood in 1935. Later Dr.Butler in 1936 described the pathophysiology and genetic inheritance of renal tubular acidosis in the children.

Historical Perspective

  • In 1935, Lightwood was the first to discover and describe renal tubular acidosis in detail.[1]
  • In 1936, Butler was the first to describe in detail about the patho-physiology and inheritance of renal tubular acidosis in children.[2]
  • In 1945, Baines was the first describe renal tubular acidosis it in adults.

References

  1. “British Paediatric Association: Proceedings of the Eighth Annual General Meeting”. Archives of Disease in Childhood. 10 (57): 205–210. 1935. doi:10.1136/adc.10.57.205. ISSN 0003-9888.
  2. Butler, Allan M.; Wilson, James L.; Farber, Sidney (1936). “Dehydration and acidosis with calcification at renal tubules”. The Journal of Pediatrics. 8 (4): 489–499. doi:10.1016/S0022-3476(36)80111-5. ISSN 0022-3476.
Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2] Syed Ahsan Hussain, M.D.[3] Jogeet Singh Sekhon, M.D. [4]

Overview

Based on underlying defect in concentration of urine process in renal tubule, renal tubular acidosis can be classified into type 1 (distal), type 2 (proximal), type 4 (hypoaldosteronism) and voltage-dependent RTA.

Classification

Renal tubular acidosis can be classified into 4 types. Renal tubular acidosis type 1( distal), renal tubular acidosis type 2 ( proximal), hypoaldosteronism (type 4) and voltage-dependent RTA. Potassium is the most common electrolyte abnormality associated renal tubular acidosis. Hypokalemia is seen in RTA type 1 and type 2 while type 4 and voltage-dependent RTA are hyperkalemic.[1][2][3]

Type of RTA Primary defect Plasma HCO3 mEq/L Urine pH Plasma potassium Urine anion gap Urine calcium/creatinine ratio Risk for nephrolithiasis
RTA type 1 Impaired distal acidification < 10 >5.3 Hypokalemic Positive
RTA type 2 Reduced proximal HCO3 reabsorption. 12 to 20 <5.3 Hypokalemic Negative Normal
RTA type 3 Mixed (distal+ proximal RTA) Variable Variable Variable Variable Variable Variable
RTA type 4 Decreased aldosterone secretion 

Aldosterone resistance

>17 Variable Hyperkalemia Positive Normal
Voltage-dependent RTA Reduced sodium reabsorption >17 Variable Hyperkalemia Positive Normal

References

  1. Gil-Peña H, Mejía N, Santos F (April 2014). “Renal tubular acidosis”. J. Pediatr. 164 (4): 691–698.e1. doi:10.1016/j.jpeds.2013.10.085. PMID 24345454.
  2. Rodriguez-Soriano J, Edelmann CM (1969). “Renal tubular acidosis”. Annu. Rev. Med. 20: 363–82. doi:10.1146/annurev.me.20.020169.002051. PMID 4894504.
  3. Morris RC (December 1969). “Renal tubular acidosis. Mechanisms, classification and implications”. N. Engl. J. Med. 281 (25): 1405–13. doi:10.1056/NEJM196912182812508.
Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2] Syed Ahsan Hussain, M.D.[3] Jogeet Singh Sekhon, M.D. [4]

Overview

Kidneys reabsorb the filtered bicarbonate and excrete acid to maintain acid-base balance. HCO3 reabsorption is facilitated by Na-H and proton pumps. Collecting tubules serve the function of excretion of acid. Renal tubular acidosis is described as any one of a number of disorders, in which either of above buffering mechanism is impaired. Potassium is the most common electrolyte abnormality that can be noticed with renal tubular acidosis. It can be either hypokalemic renal tubular acidosis or hyperkalemic renal tubular acidosis. Mode of inheritance can autosomal dominant or recessive depending upon type of disease abnormality, Common genes involved include ATP6V1B1, ATP6V0A4, SLC4A1.

Pathophysiology

Normal Physiology of Acid-Base balance

  • Normally kidneys reabsorb the filtered bicarbonate and excrete acid to maintain acid-base balance.[1][2]
  • HCO3 reabsorption is facilitated by Na-H and proton pumps.
    • Na-H reabsorbs about 80-90% of the filtered HCO3 at the proximal tubule.
    • Proton pumps (H-ATPase and H-K ATPase) in the distal nephron reabsorbs remaining 10 percent of HCO3.
    • There is no HCO3 in the final urine.
  • Collecting tubules serve the function of excretion of acid.[3][4]
    • Hydrogen ions need a buffer to get excreted.
    • The principal buffers in the urine are ammonia and phosphate.
      • Acidosis stimulates ammonia production in renal tubules.
      • While ammonia can freely diffuse across membranes, ammonium cannot.
      • The secretion of hydrogen ions into the tubular lumen trap ammonia as ammonium which can easily flush out along with .
      • Increased production of ammonium is required in cases of acidosis to maintain near-normal balance.
Source:By Haisook at English Wikipedia, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=2945979

Potassium abnoralities

  • Potassium is the most common electrolyte abnormality that can be noticed with renal tubular acidosis.[5][6]
  • It can be either hypokalemic renal tubular acidosis or hyperkalemic renal tubular acidosis.
  • Almost all of the filtered potassium is reabsorbed passively in the proximal tubule and loop of Henle.
  • The potassium excreted in the urine is derived from secretion into the tubular lumen by cells in the distal nephron.
  • Distal potassium secretion is primarily influenced by two factors, both promote sodium reabsorption:
  • Depending upon the site of the defect and the mechanism responsible for the various forms of renal tubular acidosis, can result in hypokalemia or hyperkalemia:
  • Hypokalemia frequently develops in patients with distal renal tubular acidosis.
    • Usually improves with alkali therapy in contrast to to hypokalemia in proximal renal tubular acidosis which is exacerbated by alkali therapy.
  • Hyperkalemia occurs frequently with hypoaldosteronism (type 4 ) and in patients with other defects in distal nephron sodium reabsorption (voltage-dependent renal tubular acidosis).
  • Hypokalemic renal tubular acidosis
    • Type 1 renal tubular acidosis
    • Type 2 renal tubular acidosis
  • Hyperkalemic renal tubular acidosis
    • Type 4 renal tubular acidosis
    • Voltage-dependent renal tubular acidosis

Distal renal tubular acidosis

  • Type 1 renal tubular acidosis is characterized by impaired hydrogen ion secretion in the distal nephron.
  • If left untreated, it results in progressive hydrogen ion retention leading to normal anion gap metabolic acidosis.
  • Type 1 renal tubular acidosis results in hypokalemia.
  • Impaired hydrogen ion secretion in patients with distal renal tubular acidosis can be caused by several defects:
    • Decreased net activity of the proton pump.
    • Increased hydrogen ion permeability of the luminal membrane.
Cartoon of the alpha-intercalated cell, showing the apical proton pump and the basolateral band 3 (kAE1)

Incomplete distal renal tubular acidosis

  • Incomplete distal renal tubular acidosis is a variant in which patients cannot acidify their urine, resulting in a urine pH that is persistently 5.5 or higher.
  • The low rate of citrate excretion and relatively high rate of ammonium excretion are believed to the inciting factor for a reduced intracellular pH within the cells of the proximal tubule .
  • Persistent hypo-citraturia is a consistent feature of incomplete renal tubular acidosis.

Proximal renal tubular acidosis

  • Proximal renal tubular acidosis is characterized by a decrease in re-absorption of bicarbonate in the proximal tubule.
  • Within proximal tubule cells, hydrogen ions and bicarbonate are generated from carbonic acid.
  • Na-K-ATPase pump facilitates the movement of sodium down the electrochemical concentration gradient from the lumen into the cells.
  • This concentration gradient drives hydrogen ions in the opposite direction which is counter balanced by bicarbonate ions via a sodium-bicarbonate cotransporter.
  • The net effect of this process is that, for every hydrogen ion molecule secreted into the lumen, a bicarbonate molecule enters the peritubular capillary.
  • Abnormalities of one or more of these proximal tubule transporters, pumps, or enzymes can impair sodium bicarbonate reabsorption and cause the bicarbonate wasting found in proximal renal tubular acidosis.

Hyperkalemic renal tubular acidosis

Most common causes of hyperkalemic renal tubular acidosis include:

  • Voltage-dependent renal tubular acidosis

Voltage-dependent renal tubular acidosis

  • Voltage-dependent renal tubular acidosis occurs with markedly reduced distal sodium delivery
  • Inherited or acquired defects in sodium reabsorption by the principal cells.
  • Most common etiology include

Hypoaldosteronism

  • Aldosterone deficiency or resistance produces a hyperkalemic renal tubular acidosis.[7]
  • Type 4 renal tubular acidosis is associated with milder
  • The acidification defect is primarily due to a reduced rate of proton secretion.
  • Thus, when very little buffer (ammonia [NH3] and/or phosphate) is present in the renal tubule lumen, the pH can be appropriately reduced below pH 5.5 (but the quantity of excreted acid is relatively low).
  • By contrast, when greater amounts of buffer are present in the distal tubule, the impaired rate of hydrogen ion secretion produces a faster rise in the urine pH above 5.5 than is seen in normal subjects.
  • In either case, the reduction in net acid excretion results in metabolic acidosis.

Patients with hyperkalemia usually have lower urine ammonia levels and, therefore, a more acidic urine. The defect produced by the various forms of voltage-dependent distal RTA discussed above is similar but generally more severe. In that disorder, the urine pH often cannot be reduced below 5.5 but can also vary with the rate of urine ammonia excretion.

Type of RTA Primary defect Plasma HCO3 mEq/L Urine pH Plasma potassium Urine anion gap Urine calcium/creatinine ratio Risk for nephrolithiasis
RTA type 1 Impaired distal acidification < 10 >5.3 Hypokalemic Positive
RTA Type 2 Reduced proximal HCO3 reabsorption. 12 to 20 <5.3 Hypokalemic Negative Normal
RTA type 4 Decreased aldosterone secretion 

Aldosterone resistance

>17 Variable Hyperkalemia Positive Normal
Voltage-dependent RTA Reduced sodium reabsorption >17 Variable Hyperkalemia Positive Normal

Associated Conditions

Common conditions associated with renal tubular acidosis include:

Genetics

  • DRTA may be inherited as an autosomal dominant or recessive trait.[8]
    • Autosomal recessive DRTA often presents in infancy
    • Autosomal dominant DRTA may not present until adolescence or young adulthood.
    • Mutations in the genes encoding carbonic anhydrase II, kidney anion exchanger 1 (kAE1), and subunits of the renal proton pump (H+‐ATPase) have been identified in patients with DRTA.
  • Genetically transmitted PRTAs include autosomal dominant and recessive forms.
    • PRTA (with ocular abnormalities) may be caused by inactivating mutations in the Na/HCO3 cotransporter gene (SLC4A4).
    • PRTA may also be associated with other genetically transmitted disorders, such as osteopetrosis with carbonic anhydrase II deficiency.
  • Inherited defects leading to Type 4 RTA are due to aldosterone deficiency or resistance.
Type of RTA Gene Gene location Protein
Type 1 (distal) RTA Autosomal recessive with deafness ATP6V1B1 2p13 B1 subunit of H-ATPase
Autosomal recessive without deafness ATP6V0A4 7q33-q34 a4 subunit of H-ATPase
Autosomal dominant SLC4A1 17q21-q22 Chloride-bicarbonate exchanger
Type 2 (proximal) RTA Autosomal recessive SLC4A4 4q21 Sodium bicarbonate cotransporter
Type 3 (mixed) RTA Autosomal recessive Carbonic anhydrase II 8q22 Carbonic anhydrase II

References

  1. Soleimani M, Burnham CE (February 2000). “Physiologic and molecular aspects of the Na+:HCO3- cotransporter in health and disease processes”. Kidney Int. 57 (2): 371–84. doi:10.1046/j.1523-1755.2000.00857.x. PMID 10652014.
  2. Rodríguez Soriano J (August 2002). “Renal tubular acidosis: the clinical entity”. J. Am. Soc. Nephrol. 13 (8): 2160–70. PMID 12138150.
  3. Wagner CA, Geibel JP (2002). “Acid-base transport in the collecting duct”. J. Nephrol. 15 Suppl 5: S112–27. PMID 12027210.
  4. Stanton BA (November 1989). “Renal potassium transport: morphological and functional adaptations”. Am. J. Physiol. 257 (5 Pt 2): R989–97. doi:10.1152/ajpregu.1989.257.5.R989. PMID 2686470.
  5. Pereira PC, Miranda DM, Oliveira EA, Silva AC (March 2009). “Molecular pathophysiology of renal tubular acidosis”. Curr. Genomics. 10 (1): 51–9. doi:10.2174/138920209787581262. PMC 2699831. PMID 19721811.
  6. Szylman, Pedro; Better, Ori S.; Chaimowitz, Cidio; Rosler, Ariel (1976). “Role of Hyperkalemia in the Metabolic Acidosis of Isolated Hypoaldosteronism”. New England Journal of Medicine. 294 (7): 361–365. doi:10.1056/NEJM197602122940703. ISSN 0028-4793.
  7. Szylman, Pedro; Better, Ori S.; Chaimowitz, Cidio; Rosler, Ariel (1976). “Role of Hyperkalemia in the Metabolic Acidosis of Isolated Hypoaldosteronism”. New England Journal of Medicine. 294 (7): 361–365. doi:10.1056/NEJM197602122940703. ISSN 0028-4793.
  8. Karet FE (August 2002). “Inherited distal renal tubular acidosis”. J. Am. Soc. Nephrol. 13 (8): 2178–84. PMID 12138152.
Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2] Jogeet Singh Sekhon, M.D. [3] Syed Ahsan Hussain, M.D.[4]

Ovevriew

Primary causes of renal tubular acidosis include genetic mutations causing defects in the kidney anion exchanger [kAE1] in distal tubule intercalated cells and congenital adrenal hyperplasia. Secondary causes include medications and autoimmune diseases.

Causes

The following table summarizes the common primary and secondary causes of renal tubular acidosis.[1][2][3]

Primary Causes Secondary Causes
Type 1
  • Familial
    • Autosomal dominant
      • Mainly due to mutations causing defects in the kidney anion exchanger [kAE1] in distal tubule intercalated cells.
  • Autosomal recessive
    • Mainly due to mutations causing defects in V-ATPase in distal tubule intercalated cells.
Type 2
Type 4

References

  1. Haque SK, Ariceta G, Batlle D (December 2012). “Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies”. Nephrol. Dial. Transplant. 27 (12): 4273–87. doi:10.1093/ndt/gfs493. PMC 3616759. PMID 23235953.
  2. Batlle D, Haque SK (October 2012). “Genetic causes and mechanisms of distal renal tubular acidosis”. Nephrol. Dial. Transplant. 27 (10): 3691–704. doi:10.1093/ndt/gfs442. PMID 23114896.
  3. Alper SL (2010). “Familial renal tubular acidosis”. J. Nephrol. 23 Suppl 16: S57–76. PMID 21170890.
Differentiating Renal tubular acidosis from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Renal tubular acidosis must be differentiated form other diseases as most of them have a similar presentation of acidosis on ABG, dehydration (nausea and vomiting) and specific history pertaining to underlying etiology.

Differentiating Renal tubular acidosis from other diseases

Renal tubular acidosis must be differentiated form other diseases as most of them have a similar presentation of acidosis on ABG, dehydration (nausea and vomiting) and specific history pertaining to underlying etiology.


Category Disease Mechanism Clinical Paraclinical Gold standard diagnosis Other findings
Symptoms Signs Lab data
ABG CBC Chemistry Renal U/A
↑ acid

production

Loss of

bicarbonate

↓ renal acid

excretion

Fever N/V Diarrhea Dyspnea Toxic/ill BP Dehydration Level of consciousness HCO3 paCO2 O2 WBC Hb BS Cl K+ Na+ Ketones Lactic acid Serum AG[1] Osmolar gap[2] Bun Cr Urine pH Urine AG Urine ketone
Ketoacidosis Diabetic ketoacidosis[3] + + + + + + + Nl to ↓ Nl to ↑ ↑↑ Nl Nl to ↑ Nl + + Clinical + hyperglycemia + ketosis
  • Labs might show elevated K+ even in K+ depletion due to extravasation of intracellular K+ in exchanged with extracellular H+
Starvation[4] + + + + Nl Nl Nl Nl to ↓ Nl Nl Nl Nl Nl Nl + Clinical manifestation
Alcoholic ketoacidosis (Ethanol)[5] + + ± + ↓ ↑ + Agitated Nl to ↑ Nl to ↑ ↓ Nl ↑ Nl ↑↑ ↑↑ Nl + + Clinical manifestation + ketosis
Systemic Sepsis[6] + + + + + ↓ ↑ + Nl to ↓ Nl Nl Nl Nl Nl to ↑ Nl Nl Nl Clinical manifestation and lab finding
  • Not applicable
Ischemia[7] + + + + + ↓ ↑ Nl to ↓ Nl to ↑ Nl Nl Nl Nl Nl to ↑ Nl Nl Nl to ↑ Nl to ↑ Nl Clinical manifestation and lab finding
  • Not applicable
Lactic acidosis[8] + ± + + ↓ ↑ ± Agitated Nl to ↑ Nl Nl Nl Nl Nl Nl or ↑ Nl Clinical manifestation and lab finding
  • Not applicable
Renal Uremia[9] + + + + ↓ ↑ ± Nl to ↓ Nl Nl Nl Nl + Clinical manifestation and lab finding
Renal failure[10] + + + + Nl to ↓ Nl Nl Nl Renal function test
  • Not applicable
Renal tubular acidosis[11] Type I[12] + ± ± ↓ ↑ Nl Nl Nl Nl Nl Nl Nl Nl + Clinical manifestation and lab finding
Type II + ± ± ↓ ↑ Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Clinical manifestation and lab finding
  • Not applicable
Type IV + ± ± ± Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl + Clinical manifestation and lab finding
Heart Heart failure[13] + + ± + + ↓ ↑ + ↓ ↑ Nl Nl Nl Nl Nl Nl Nl Nl Nl to ↑ Nl to ↑ Nl Clinical manifestation+ echocardiogram
Myocardial infarction[14] + + + + ↓ ↑ ↓ ↑ Nl to ↓ Nl to ↑ Nl Nl Nl Nl Nl Nl Nl to ↑ Nl to ↑ Nl Clinical manifestation + ECG
  • Not applicable
GI Diarrhea[15] + ± + + + + May be lethargic Nl Nl Nl Nl Nl Nl Nl Nl Nl Stool exam
  • Not applicable
Hyperalimentation[16] + + + Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Clinical manifestation
  • Not applicable
Liver failure[17] + + + + + Confused Nl Nl ↓ ↑ Nl Nl Nl Nl Nl Nl Nl Liver biopsy
  • Not applicable
Endocrine Hyperparathyroidism[18] + + + Nl + Confused Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl to ↑ Nl Nl PTH level
  • Not applicable
Addison’s disease[19] + + + + Irritable Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Hormone level

References

  1. Brubaker RH, Meseeha M. High Anion Gap Metabolic Acidosis. [Updated 2017 Oct 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448090/
  2. Kraut JA, Xing SX (September 2011). “Approach to the evaluation of a patient with an increased serum osmolal gap and high-anion-gap metabolic acidosis”. Am. J. Kidney Dis. 58 (3): 480–4. doi:10.1053/j.ajkd.2011.05.018. PMID 21794966.
  3. Wolfsdorf, Joseph I; Allgrove, Jeremy; Craig, Maria E; Edge, Julie; Glaser, Nicole; Jain, Vandana; Lee, Warren WR; Mungai, Lucy NW; Rosenbloom, Arlan L; Sperling, Mark A; Hanas, Ragnar (2014). “Diabetic ketoacidosis and hyperglycemic hyperosmolar state”. Pediatric Diabetes. 15 (S20): 154–179. doi:10.1111/pedi.12165. ISSN 1399-543X.
  4. Mostert M, Bonavia A (October 2016). “Starvation Ketoacidosis as a Cause of Unexplained Metabolic Acidosis in the Perioperative Period”. Am J Case Rep. 17: 755–758. PMC 5070574. PMID 27752032.
  5. Howard RD, Bokhari S. PMID 28613672. Vancouver style error: initials (help); Missing or empty |title= (help)
  6. Ganesh K, Sharma RN, Varghese J, Pillai MG (2016). “A profile of metabolic acidosis in patients with sepsis in an Intensive Care Unit setting”. Int J Crit Illn Inj Sci. 6 (4): 178–181. doi:10.4103/2229-5151.195417. PMC 5225760. PMID 28149822.
  7. Kimmoun, Antoine; Novy, Emmanuel; Auchet, Thomas; Ducrocq, Nicolas; Levy, Bruno (2015). “Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside”. Critical Care. 19 (1). doi:10.1186/s13054-015-0896-7. ISSN 1364-8535.
  8. Kraut, Jeffrey A.; Ingelfinger, Julie R.; Madias, Nicolaos E. (2014). “Lactic Acidosis”. New England Journal of Medicine. 371 (24): 2309–2319. doi:10.1056/NEJMra1309483. ISSN 0028-4793.
  9. Brown, Denver; Melamed, Michal L. (2018). “New Frontiers in Treating Uremic Metabolic Acidosis”. Clinical Journal of the American Society of Nephrology. 13 (1): 4–5. doi:10.2215/CJN.11771017. ISSN 1555-9041.
  10. Kraut, Jeffrey A.; Madias, Nicolaos E. (2016). “Metabolic Acidosis of CKD: An Update”. American Journal of Kidney Diseases. 67 (2): 307–317. doi:10.1053/j.ajkd.2015.08.028. ISSN 0272-6386.
  11. Gil-Peña, Helena; Mejía, Natalia; Santos, Fernando (2014). “Renal Tubular Acidosis”. The Journal of Pediatrics. 164 (4): 691–698.e1. doi:10.1016/j.jpeds.2013.10.085. ISSN 0022-3476.
  12. Hemstreet, Brian A (2004). “Antimicrobial-Associated Renal Tubular Acidosis”. Annals of Pharmacotherapy. 38 (6): 1031–1038. doi:10.1345/aph.1D573. ISSN 1060-0280.
  13. Park, Jin Joo; Choi, Dong-Ju; Yoon, Chang-Hwan; Oh, Il-Young; Lee, Ju Hyun; Ahn, Soyeon; Yoo, Byung-Su; Kang, Seok-Min; Kim, Jae-Joong; Baek, Sang-Hong; Cho, Myeong-Chan; Jeon, Eun-Seok; Chae, Shung Chull; Ryu, Kyu-Hyung; Oh, Byung-Hee (2015). “The prognostic value of arterial blood gas analysis in high-risk acute heart failure patients: an analysis of the Korean Heart Failure (KorHF) registry”. European Journal of Heart Failure. 17 (6): 601–611. doi:10.1002/ejhf.276. ISSN 1388-9842.
  14. Mann, Sarah; Bajulaiye, Akinyemi; Sturgeon, Kathleen; Sabri, Abdelkarim; Muthukumaran, Geetha; Libonati, Joseph R. (2014). “Effects of acute angiotensin II on ischemia reperfusion injury following myocardial infarction”. Journal of the Renin-Angiotensin-Aldosterone System. 16 (1): 13–22. doi:10.1177/1470320314554963. ISSN 1470-3203.
  15. Guerrant, R. L.; Van Gilder, T.; Steiner, T. S.; Thielman, N. M.; Slutsker, L.; Tauxe, R. V.; Hennessy, T.; Griffin, P. M.; DuPont, H.; Bradley Sack, R.; Tarr, P.; Neill, M.; Nachamkin, I.; Reller, L. B.; Osterholm, M. T.; Bennish, M. L.; Pickering, L. K. (2001). “Practice Guidelines for the Management of Infectious Diarrhea”. Clinical Infectious Diseases. 32 (3): 331–351. doi:10.1086/318514. ISSN 1058-4838.
  16. Erlingsson, Styrbjörn; Herard, Sebastian; Dahlqvist Leinhard, Olof; Lindström, Torbjörb; Länne, Toste; Borga, Magnus; Nystrom, Fredrik H. (2009). “Men develop more intraabdominal obesity and signs of the metabolic syndrome after hyperalimentation than women”. Metabolism. 58 (7): 995–1001. doi:10.1016/j.metabol.2009.02.028. ISSN 0026-0495.
  17. Lange, Christian M.; Bojunga, Jörg; Hofmann, Wolf Peter; Wunder, Katrin; Mihm, Ulrike; Zeuzem, Stefan; Sarrazin, Christoph (2009). “Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function”. Hepatology. 50 (6): 2001–2006. doi:10.1002/hep.23346. ISSN 0270-9139.
  18. Bilezikian, John P.; Potts, John T.; Fuleihan, Ghada El-Hajj; Kleerekoper, Michael; Neer, Robert; Peacock, Munro; Rastad, Jonas; Silverberg, Shonni J.; Udelsman, Robert; Wells, Samuel A. (2002). “Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century”. The Journal of Clinical Endocrinology & Metabolism. 87 (12): 5353–5361. doi:10.1210/jc.2002-021370. ISSN 0021-972X.
  19. Ten, Svetlana; New, Maria; Maclaren, Noel (2001). “Addison’s Disease 2001”. The Journal of Clinical Endocrinology & Metabolism. 86 (7): 2909–2922. doi:10.1210/jcem.86.7.7636. ISSN 0021-972X.
Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

The estimated annual incidence of distal renal tubular acidosis is 10 in 100,000 population. Renal tubular acidosis is more common in infants than other group of population. There is a racial predilection for renal tubular acidosis.

Epidemiology

Incidence

  • The estimated annual incidence of distal renal tubular acidosis is 10 in 100,000 population.
  • Proximal renal tubular acidosis is less common than distal renal tubular acidosis.

Demographics

Age

  • Renal tubular acidosis is more common in infants than the other group of population.[1]

Gender

  • Distal renal tubular acidosis affects men and women equally.
  • However, proximal renal tubular acidosis is more common in males than females.

Race

  • There is racial predilection for renal tubular acidosis.

References

  1. Weger W, Kotanko P, Weger M, Deutschmann H, Skrabal F (July 2000). “Prevalence and characterization of renal tubular acidosis in patients with osteopenia and osteoporosis and in non-porotic controls”. Nephrol. Dial. Transplant. 15 (7): 975–80. PMID 10862634.
Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Common risk factors in the development of renal tubular acidosis include urinary tract obstruction, diabetes mellitus, primary biliary cirrhosis, nephrocalcinosis, nephrolithiasis, Amphotericin-B therapy, cisplatinum, Untreated adrenal insufficiency.

Risk factors

Common risk factors in the development of renal tubular acidosis include:[1][2][3][4]

Less Common Risk Factors

Less common risk factors in the development of renal tubular acidosis include:

References

  1. Malik SI, Naqvi R, Ahmed E, Zafar MN (January 2011). “Prevalence and risk factors of renal tubular acidosis after kidney transplantation”. J Pak Med Assoc. 61 (1): 23–7. PMID 22368897.
  2. Uribarri J, Oh MS, Pak CY (June 1994). “Renal stone risk factors in patients with type IV renal tubular acidosis”. Am. J. Kidney Dis. 23 (6): 784–7. PMID 8203358.
  3. Caruana RJ, Buckalew VM (March 1988). “The syndrome of distal (type 1) renal tubular acidosis. Clinical and laboratory findings in 58 cases”. Medicine (Baltimore). 67 (2): 84–99. PMID 3127650.
  4. Donnelly S, Kamel KS, Vasuvattakul S, Narins RG, Halperin ML (March 1992). “Might distal renal tubular acidosis be a proximal tubular cell disorder?”. Am. J. Kidney Dis. 19 (3): 272–81. PMID 1553972.
Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Screening for renal tubular acidosis is usually not recommended for asymptomatic patients. Screening is only recommended for patients with increased risk of having proximal RTA or metabolic disorders associated with the development of Fanconi syndrome.

Screening

References

  1. Guerra-Hernández NE, Ordaz-López KV, Escobar-Pérez L, Gómez-Tenorio C, García-Nieto VM (2015). “Distal Renal Tubular Acidosis Screening by Urinary Acidification Testing in Mexican Children”. Rev. Invest. Clin. 67 (3): 191–8. PMID 26202743.
  2. Yaxley J, Pirrone C (2016). “Review of the Diagnostic Evaluation of Renal Tubular Acidosis”. Ochsner J. 16 (4): 525–530. PMC 5158160. PMID 27999512.
Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

If left untreated renal tubular acidosis leads to growth failure and chronic kidney failure. Common complications associated with renal tubular acidosis include volume depletion, electrolyte disturbances, nephrocalcinosis, osteoporosis, growth retardation, renal rickets. Prognosis of renal tubular acidosis is generally good with appropriate therapy.

Natural History

If left untreated renal tubular acidosis leads to growth failure and chronic kidney failure leading to electrolyte disturbances, bone abnormalities, cranial nerve compression and in severe cases it may lead to heart failure and death.[1]

Complications

Common complications associated with renal tubular acidosis include:[2][3]

  • Volume depletion
  • Electrolyte disturbances
  • Nephrocalcinosis
  • Osteoporosis
  • Growth retardation
  • Renal rickets
  • Fludrocortisone-associated hypertension and edema or pulmonary edema
  • Osteopetrosis

Prognosis

  • Prognosis of renal tubular acidosis is generally good with appropriate therapy.[4][5]
  • Alkali therapy seems effective in prevention of renal stones and nephro-calcinosis in patients with incomplete distal renal tubular acidosis.
  • Aggressive correction of acidosis has been shown to restore growth in children with renal tubular acidosis.
  • Effective treatment proved no effect on already occurred damage such as blindness and deafness due to nerve compression.
  • The prognosis of Fanconi syndrome depend on etiology.
    • In inherited metabolic disease, it is of poor prognosis .
    • When it is secondary due to drugs or toxin exposure, prognosis is generally good as it regresses on with drawl of the offending agent.

References

  1. Laing CM, Unwin RJ (2006). “Renal tubular acidosis”. J. Nephrol. 19 Suppl 9: S46–52. PMID 16736441.
  2. Tsau YK, Chen CH, Tsai WS, Chiou YM (1990). “Renal tubular acidosis in childhood”. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 31 (4): 205–13. PMID 2264480.
  3. Harrington TM, Bunch TW, Van den Berg CJ (June 1983). “Renal tubular acidosis. A new look at treatment of musculoskeletal and renal disease”. Mayo Clin. Proc. 58 (6): 354–60. PMID 6222224.
  4. Tsau YK, Chen CH, Tsai WS, Chiou YM (1990). “Renal tubular acidosis in childhood”. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 31 (4): 205–13. PMID 2264480.
  5. Santos F, Chan JC (1986). “Renal tubular acidosis in children. Diagnosis, treatment and prognosis”. Am. J. Nephrol. 6 (4): 289–95. doi:10.1159/000167177. PMID 3777038.
Diagnosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

References

References

Template:Nephrology


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH